Back to Search
Start Over
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): a double-blind, multicentre, randomised, controlled trial
- Source :
- The Lancet Regional Health - Americas; 20220101, Issue: Preprints
- Publication Year :
- 2022
-
Abstract
- Previous Randomised controlled trials (RCT) evaluating chloroquine and hydroxychloroquine in non-hospitalised COVID-19 patients have found no significant difference in hospitalisation rates. However, low statistical power precluded definitive answers.
Details
- Language :
- English
- ISSN :
- 2667193X
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- The Lancet Regional Health - Americas
- Publication Type :
- Periodical
- Accession number :
- ejs59205136
- Full Text :
- https://doi.org/10.1016/j.lana.2022.100243